IPO Trending
INFLUXSME / NSEListed
Influx Healthtech

Influx Healthtech Limited, established in September 2020, is a healthcare-focused company that provides contract manufacturing services. It operates as a trusted CDMO (Contract Development and Manufacturing Organization), serving clients across various sectors. The company runs three manufacturing units located in Thane, Maharashtra, with facility sizes of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its product range includes tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules, candies, gym and sports supplements, as well as skincare, body care, hair care, beard care products, face masks, and soaps. It also manufactures ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company supports nutraceutical and cosmetic businesses by handling the entire process from product development to manufacturing and regulatory assistance, allowing clients to concentrate on formulation and market launch. As of June 11, 2025, Influx Healthtech Limited employs 163 full-time staff members.

₹91 - ₹96201.44x sub
Listed Price₹132.50
Listing Gain+38.02%

Subscription Status

201.44xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB137.87x
🔥 Blockbuster Sizzling Demand!Offered: 11,59,200 sh
Nib481.47x
🔥 Blockbuster Sizzling Demand!Offered: 8,70,000 sh
Retail117.70x
🔥 Blockbuster Sizzling Demand!Offered: 20,29,200 sh
CategoryOfferedAppliedTimes
QIB11,59,20015,98,18,400137.87x
Nib8,70,00041,88,78,000481.47x
Retail20,29,20023,88,42,000117.7x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB1,534.2611.13137.85x
Retail2,292.8819.48117.70x

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
QIB099Open
Nib021,204Open
Retail01,99,035Open
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Influx Healthtech IPO Subscription Demand

Live subscription status and bidding analysis for Influx Healthtech (INFLUX) IPO. The issue is subscribed 201.44x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions